TrialNature medicine2025

Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trial.

Zijing Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.